Literature DB >> 19513898

Cutaneous human papillomavirus in head and neck squamous cell carcinomas.

Katja Lindel1, Burkhard Helmke, Christian Simon, Klaus J Weber, Juergen Debus, Ethel-Michele de Villiers.   

Abstract

To evaluate the prevalence and meaning of cutaneous human papillomavirus (HPV) types in HNSCC 51 patients were analyzed for the prevalence of cutaneous as well as mucosal HPV. HPV DNA was demonstrated in 18 (35%) of 51 tumors. The majority of these HPV types belong to so-called cutaneous HPV types, whereas only HPV 6 and HPV 16 were from the mucosal HPV types. A possible role for cutaneous HPV types as co-factors in the oncogenesis of HNSCC remains to be elucidated and may be relevant for future strategies of cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513898     DOI: 10.1080/07357900802653456

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  3 in total

1.  Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Christopher B Buck; Kihyuck Kwak; Richard B S Roden; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2012-09-15       Impact factor: 3.616

2.  High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study.

Authors:  Laura Sichero; Christine M Pierce Campbell; William Fulp; Silvaneide Ferreira; João S Sobrinho; Maria Baggio; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa
Journal:  BMC Infect Dis       Date:  2014-12-09       Impact factor: 3.090

Review 3.  Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis.

Authors:  Seye Abogunrin; Gian Luca Di Tanna; Sam Keeping; Stuart Carroll; Ike Iheanacho
Journal:  BMC Cancer       Date:  2014-12-17       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.